Cingulate Warrants Stock Today
CINGW Stock | USD 0.05 0.01 11.56% |
Performance8 of 100
| Odds Of DistressOver 75
|
Cingulate Warrants is selling for under 0.052 as of the 30th of January 2025; that is 11.56 percent down since the beginning of the trading day. The stock's lowest day price was 0.0462. Cingulate Warrants has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 30th of January 2025. Click here to learn more.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey. More on Cingulate Warrants
Moving against Cingulate Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cingulate Stock Highlights
CEO Board | Shane PharmD |
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Financial Strength |
Cingulate Warrants (CINGW) is traded on NASDAQ Exchange in USA. It is located in 1901 West 47th Place, Kansas City, KS, United States, 66205 and employs 13 people. Cingulate Warrants is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Cingulate Warrants has accumulated about 1.92 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cingulate Warrants Probability Of Bankruptcy
Cingulate Warrants Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cingulate Warrants market risk premium is the additional return an investor will receive from holding Cingulate Warrants long position in a well-diversified portfolio.
Risk Adjusted Performance | 0.0956 | |||
Jensen Alpha | 2.03 | |||
Total Risk Alpha | (0.11) | |||
Sortino Ratio | 0.0998 |
Cingulate Stock Against Markets
Cingulate Warrants Corporate Executives
Elected by the shareholders, the Cingulate Warrants' board of directors comprises two types of representatives: Cingulate Warrants inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate Warrants' management team and ensure that shareholders' interests are well served. Cingulate Warrants' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate Warrants' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jennifer CPA | Senior CFO | Profile | |
Dr MBA | Executive COO | Profile |
Additional Tools for Cingulate Stock Analysis
When running Cingulate Warrants' price analysis, check to measure Cingulate Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate Warrants is operating at the current time. Most of Cingulate Warrants' value examination focuses on studying past and present price action to predict the probability of Cingulate Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate Warrants' price. Additionally, you may evaluate how the addition of Cingulate Warrants to your portfolios can decrease your overall portfolio volatility.